Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

• December 16, 2025
• HealthDayTV HealthDay Reporter

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”

El servicio de noticias de salud es un servicio para los usuarios de la página web de Hawthorne Drug Co. gracias a HealthDay. Hawthorne Drug Co. ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.

Derechos de autor © 2026 HealthDay Reservados todos los derechos.

Etiquetas